LYTIR

Insider · SEC Form 4 · President and CEO

Troy E. Wilson

Filed with the SEC as WILSON TROY EDWARD; the order above is the one the filer's own signature uses.

In the 12 months to Nov 19, 2026, on the open market: bought $5.4M of KURA; sold $123K of PBYI. Filed a median of 0 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $5.4M in total; Insider sales: $123K in total.Jun: Insider sales $78KAug: Insider purchases $2.4MSep: Insider sales $46KNov: Insider purchases $3.0MDecJanFebMarAprMayJunJulAugSepOctNov$3.0M$78K
Insider purchases above the line: $5.4MInsider sales below: $123K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. KURABought: Kura Oncology, Inc. Nov 16, 2026 202,238 shares filed Nov 16, 2026 2 transactions filing $1.5M
  2. KURABought: Kura Oncology, Inc. Nov 13, 2026 197,762 shares filed Nov 16, 2026 2 transactions filing $1.5M
  3. PBYISold: PUMA BIOTECHNOLOGY, INC. Sep 14, 2026 5,000 shares filed Sep 16, 2026 54,750 shares held directly after, as filed 10b5-1 plan filing $46K
  4. KURABought: Kura Oncology, Inc. Aug 24, 2026 100,000 shares filed Aug 24, 2026 479,194 shares held indirectly after, as filed filing $1.2M
  5. KURABought: Kura Oncology, Inc. Aug 17, 2026 100,000 shares filed Aug 17, 2026 379,194 shares held indirectly after, as filed filing $1.1M
  6. PBYISold: PUMA BIOTECHNOLOGY, INC. Jun 12, 2026 10,800 shares filed Jun 15, 2026 59,750 shares held directly after, as filed 10b5-1 plan filing $78K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Planned sales (Form 144)

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Notices filed under this filer's SEC CIK in the same 12 months, newest first; the figure is the market value the notice states. Not every notice becomes a sale. Every recent notice

  1. PBYIWILSON TROY EDWARD filed Sep 14, 2026 PUMA BIOTECHNOLOGY, INC. Director 5,000 shares planned sale date 09/14/2026 filing $46K

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • PBYI: grant or award (code A), 1 entry, Jun 11, 2026
Code A
A grant or award from the company, such as stock given as pay.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.